Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Anterior ischemic optic neuropathy (AION) can be divided into nonarteritic (NAION) and arteritic (AAION) forms. NAION makes up ~85% of all cases of AION, and until recently was poorly understood. There is no treatment for NAION, and its initiating causes are poorly understood, in part because NAION is not lethal, making it difficult to obtain fresh, newly affected tissue for study. In-vivo electrophysiology and post-mortem studies reveal specific responses that are associated with NAION. New models of NAION have been developed which enable insights into the pathophysiological events surrounding this disease. These models include both rodent and primate species, and the power of a `vertically integrated' multi-species approach can help in understanding the common cellular mechanisms and physiological responses to clinical NAION, and to identify potential approaches to treatment. The models utilize laser light to activate intravascular photoactive dye to induce capillary vascular thrombosis, while sparing the larger vessels. The observable optic nerve changes associated with rodent models of AION (rAION) and primate NAION (pNAION) are indistinguishable from that seen in clinical disease, including sectoral axonal involvement, and in-vivo electrophysiological data from these models are consistent with clinical data. Early post-infarct events reveal an unexpected inflammatory response, and changes in intraretinal gene expression for both stress response, while sparing outer retinal function, which occurs in AAION models. Histologically, the NAION models reveal an isolated loss of retinal ganglion cells by apoptosis. There are changes detectable by immunohistochemistry suggesting that other retinal cells mount a brisk response to retinal ganglion cell distress without themselves dying. The optic nerve ultimately shows axonal loss and scarring. Inflammation is a prominent early histological feature. This suggests that clinically, specific modulation of inflammation may be a useful approach to NAION treatment early in the course of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Induction of reproducible brain infarction by photochemically initiated thrombosis
Watson, B. D., Dietrich, W. D., Busto, R., Wachtel, M. S., & Ginsberg, M. D. (1985) · Annals of Neurology · doi:10.1002/ana.410170513 · Cited by 1,135
Nadal-Nicola´s, F. M., Jime´nez-Lo´pez, M., Sobrado-Calvo, P., Nieto-Lo´pez, L., Ca´novas-Marti´nez, I., Salinas-Navarro, M., Vidal-Sanz, M., & Agudo, M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3267 · Cited by 541 · cited 1×
“In this respect, both NAION and AAION are similar to other sudden axonopathic conditions, such as ON stretch, crush and axotomy (Schlamp et al., 2001; Nadal-Nicolas et al., 2009).”
Background(1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140566007 · Cited by 287
Salomon, O. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90159-8 · Cited by 204
Cited by
Biousse, V., & Newman, N. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1413352 · Cited by 341
Neuroprotective strategies for retinal disease
Pardue, M. T., & Allen, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.002 · Cited by 237
“Treatments for AION include aspirin, VEGF inhibitors, and systemic corticosteroids (Bernstein et al., 2011; Foroozan, 2017).”
Distinguishing ischaemic optic neuropathy from optic neuritis by ganglion cell analysis
Erlich‐Malona, N., Mendoza‐Santiesteban, C. E., Hedges, T. R., Patel, N., Monaco, C., & Cole, E. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13128 · Cited by 23
MacIntosh, P. W. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.01.17 · Cited by 13
Metadata
- Authors
- Bernstein, S. L., Johnson, M. A., & Miller, N. R.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 30
- Issue
- 3
- Pages
- 167-187
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2049374775
- Cited by
- 148
- References
- 5
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. https://app.cochat.ai/papers/10.1016/j.preteyeres.2011.02.003
- The paper
- Bernstein, S. L., Johnson, M. A., & Miller, N. R. (2011). Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Progress in Retinal and Eye Research. https://doi.org/10.1016/j.preteyeres.2011.02.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.